申请人:Augusta University Research Institute, Inc.
公开号:US10292978B2
公开(公告)日:2019-05-21
Methods of selectively inhibiting Akt3 are provided. It has been discovered that 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide selectively inhibits Akt3. Because Akt3 modulates the suppressive function of natural Tregs and the polarization of induced Tregs, 4-[(6-nitroquinolin-4-yl)amino]-N-[4-(pyridin-4-ylamino)phenyl]benzamide can be used for modulating immune responses.
提供了选择性抑制 Akt3 的方法。研究发现,4-[(6-硝基喹啉-4-基)氨基]-N-[4-(吡啶-4-基氨基)苯基]苯甲酰胺可选择性地抑制 Akt3。由于 Akt3 可调节天然 Tregs 的抑制功能和诱导 Tregs 的极化,因此 4-[(6-硝基喹啉-4-基)氨基]-N-[4-(吡啶-4-基氨基)苯基]苯甲酰胺可用于调节免疫反应。